By Eva Levy

Abstract

This Article analyzes the Supreme Court’s decision in Harrington v. Purdue Pharma, which blocked the Sackler family’s attempt to gain immunity through bankruptcy proceedings. The ruling establishes an important precedent limiting wealthy individuals’ ability to exploit bankruptcy law to avoid liability for corporate wrongdoing, particularly in the context of the opioid epidemic.

I. Introduction and Background of the Opioid Crisis

The opioid epidemic in the United States is a public health disaster, with over a million overdose deaths since 1999.1 Central to this epidemic is Purdue Pharma’s introduction and aggressive marketing of OxyContin, a drug that quickly became notorious for its addictive properties.2 Purdue’s actions, driven by the profit-seeking motives of the Sackler family, significantly contributed to the widespread addiction, overdose deaths, and social and economic destruction that followed.3 While the pharmaceutical giant has faced legal challenges, its attempt to use bankruptcy as a shield against accountability, particularly through the case of Harrington v. Purdue Pharma, raises critical questions about the legal system’s ability to hold corporate wrongdoers accountable.4 The Sackler family, who created Purdue Pharma, should be held accountable for their role in fueling the opioid epidemic. Harrington v. Purdue Pharma is an example of not only how bankruptcy law can be used to escape consequences but also how the legal system can overcome such instances.

II. Deceptive Marketing Practices and Initial Legal Response

Purdue Pharma’s marketing of OxyContin involved deceptive practices, since the Sacklers promoted the drug as a non-addictive solution for chronic pain.5 Purdue’s aggressive promotion of OxyContin in the late 1990s and early 2000s led to widespread abuse and addiction, which resulted in thousands of deaths and severe social and economic consequences.6 The Sackler family largely escaped meaningful accountability despite their direct involvement in Purdue’s actions, due in part to their wealth and influence.

III. The Strategic Use of Bankruptcy Protection

Such lack of accountability became evident when Purdue Pharma filed for Chapter 11 bankruptcy in 2019.7 Chapter 11 bankruptcy allows companies to restructure their debts while continuing operations. It typically involves creating a plan to repay creditors over time while gaining temporary protection from lawsuits. The company used bankruptcy protection, not to resolve its financial troubles, but as a strategic move to shield itself from thousands of lawsuits filed by victims of the opioid crisis. In exchange for a $6 billion contribution to a settlement fund, the court granted the Sackler family immunity from future lawsuits—a move that many saw as an unjust way to protect the family from facing the consequences of their actions.8

IV. Legal Challenges to the Immunity Agreement

The Sacklers’ immunity stemmed from a provision in bankruptcy law that permits third-party releases under certain conditions. The morality and legality of this immunity were questioned in the Harrington v. Purdue Pharma case.9 Initially, the Second Circuit Court of Appeals upheld the non-consensual third-party release to grant immunity to the Sacklers, even though they were not personally filing for bankruptcy. This decision hinged on the claim that the $6 billion contribution was essential for compensating victims; still, it also underscored the disturbing reality that wealthy individuals could exploit the bankruptcy system to avoid facing the repercussions of their actions. The case demonstrates how corporate leaders and their families, protected by immense wealth and legal maneuvering, can shield themselves from legal accountability, thereby undermining the justice owed to victims of their destructive actions.10

V. The Supreme Court’s Intervention

The U.S. Supreme Court ultimately ruled 5-4 against the Sacklers’ request for immunity, blocking the non-consensual third-party release.11 Justice Gorsuch’s majority opinion reinforced that bankruptcy laws are designed to protect only debtors, and that granting immunity to non-debtors like the Sacklers was an overreach of judicial authority. This ruling is significant because it rejects the notion that bankruptcy laws are a tool to shield individuals from liability, especially when they have personally benefited from the harmful corporate action. While the Court’s decision provides some measure of moral justice, it also opens up complex legal challenges for the future, particularly regarding how victims will be compensated.

VI. Implications for Corporate Accountability

The Harrington case is vital for the ongoing battle for corporate accountability, especially when it is a family that has contributed to the death and hardships of so many. For now, the outcome is a victory for dismantling the ability of the rich to conceal their mistakes. Most importantly, the Sackler family’s role in the opioid epidemic should not be allowed to fade into the background through legal loopholes and settlements that protect them from further litigation.